Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.
(20ALJ334)
Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.
(20ALJ334)Logo-themed deal toy commemorating a private placement by Viveve. The Colorado-based medical technology company specializes in women’s health.
(20AJH071)Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)Crystal deal toy commemorating a follow-on offering by medical device company TransEnterix.
(20AJH151)Crystal deal toy commemorating a loan facility provided for Biohaven Pharmaceuticals, based in New Haven, Connecticut.
(20ALJ278)Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.
(20AJH130)Deal tombstone recognizing a follow-on offering by Pennsylvania-based biotech firm Windtree Therapeutics.
(20AH070)Custom deal toy celebrating the initial public offering by South Korean firm SK Biopharmaceuticals. The listing on Seoul’s main stock exchange was the largest in South Korea since 2017. .
(20ALJ243)Crystal deal toy commemorating a capital raise by Melbourne, Australia-based Mach7 Technologies, a healthcare software provider.
(20ALJ211)
